News search

    E.g., 16/07/2026
    E.g., 16/07/2026
    Alzheimer's_Dementia
    About the CNIC
    6 Jul 2026
    Alzheimer's & Dementia: A new imaging technique locates microthrombi that worsen Alzheimer’s disease, opening the way to personalized anticoagulant therapy

    This tool paves the way for identifying patients who would be suitable candidates for treatment with anticoagulant therapy already available at the clinic 
    Participantes en el simposio ‘Understanding the Neurovascular Network to Prevent Dementia'
    About the CNIC
    4 Dec 2025
    “Understanding the Neurovascular Network to Prevent Dementia”: why understanding the neurovascular network matters for dementia prevention
    Pascual Sánchez-Juan
    Research
    13 Aug 2025
    Pascual Sánchez-Juan: “As a clinician, it frustrates me that we don’t see clear benefits for the patient”
    Dr. Jonathan Kipnis y la Dra. Mª Ángeles Moro
    About the CNIC
    30 Apr 2025
    Dr. Jonathan Kipnis: "Science isn’t just a luxury. It’s infrastructure for the future"

    Dr. Jonathan Kipnis is a Principal Investigator and the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University
    Dra. Hélène Girouard
    Research
    4 Aug 2024
    Dra. Hélène Girouard: “In alzheimer’s disease, high blood pressure is the main risk factor after age”

    Laboratory of Pharmacology and Physiology of the University of Montreal (Canadá)

    Sandro Da Mesquita
    Research
    6 Jul 2024
    Sandro Da Mesquita: “What really motivates me is understanding the mechanisms and the potential clinical benefits”

    Mayo Clinic College of Medicine and Science in Jacksonville

     
    Alberto Pascual
    Research
    11 Apr 2024
    Alberto Pascual: “Wanting to live forever is not the best thing for a species”
    Catarina Tristão Pereira, Enrique Lara Pezzi, Raquel Toribio Fernández, Borja Ibáñez, Valentín Fuster, Sergio Callejas, Marta Cortés Canteli, Ana Dopazo, Pilar Martín, Inés García Lunar e Irene Fernández Nueda.
    Research
    23 Jan 2024
    Circulation Research: APOE genetic variants linked to Alzheimer disease are also associated with the development of subclinical aterosclerosis

    The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis
    Rafael Yuste
    Research
    19 Dec 2023
    Rafael Yuste: “Because it accesses the centre of our mental activity, neurotechnology bypasses all of the filters that exist in the body
    Juan Domingo Gisbert
    About the CNIC
    24 Jun 2022
    Juan Domingo Gisbert: "Combining CNIC and BBRC data will allow us to answer questions of great relevance for the prevention of Alzheimer's in healthy subjects"

    Juan Domingo Gispert López, head of the Barcelonaβeta Brain Research Center and CNIC (Spanish National Centre for Cardiovascular Research) researcher